» Articles » PMID: 33396524

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission

Overview
Publisher MDPI
Specialty General Medicine
Date 2021 Jan 5
PMID 33396524
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Ulcerative colitis is a disease with an unpredictable evolution, often highlighted endoscopically, that is associated with persistent inflammation affecting the patient's quality of life. An attempt was made to discover surrogate markers to evaluate the endoscopic remission of the disease in order to increase the patient's quality of life and also their adherence to the treatment and monitoring plan. One such marker is fecal calprotectin (FC). To confirm the correlation between biomarkers and endoscopic disease activity and to define the optimal cut off value to detect clinical and endoscopic remission in a center of Romania. This was a prospective study that included 59 patients diagnosed with ulcerative colitis at the Department of Internal Medicine III, University Emergency Hospital of Bucharest. Patients had fecal calprotectin measurements and colonoscopy/rectosigmoidoscopy performed during baseline, 6 and 12 months. For endoscopic activity the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) was used. During the study, relapses have occurred in 35.6% of patients, the median age was 47 years (21-77). During the study, the FC measurement was significantly increased at 3 months (median, range µg/g; 715, 14-4000) and at 6 months (median, range µg/g; 650, 4.5-3000) ( ≤ 0.05). Another inflammatory biomarker studied was CRP, which showed increased values at 3 months (median, range, mg/dL; 1.86, 0.14-58.9), at 6 months (median, range, mg/dL; 2.36, 0.12-45.8) and at 9 months (median, range, mg/dl; 2, 0.12-25.9) compared to the baseline ( = 0.01). Patients with recurrence of the disease also associated an increase in the values of clinical evaluation scores (SCCAI; = 0.00001), but also endoscopic (UCEIS; = 0.0006) A relapse is associated independently with younger age, the extension of the disease (E2-E3), increased FC level, C reactive protein, hemoglobin concentration, SCCAI index and UCEIS score.

Citing Articles

A Cross-Sectional Evaluation of Disability in Inflammatory Bowel Disease Using IBD Disk in a Tertiary Center from Romania.

Muru O, Pop C, Filip P, Tiuca N, Diaconu L J Clin Med. 2024; 13(23).

PMID: 39685627 PMC: 11642591. DOI: 10.3390/jcm13237168.


Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations.

Schreiber S, Danese S, Dignass A, Domenech E, Fantini M, Ferrante M J Crohns Colitis. 2023; 18(1):91-105.

PMID: 37586038 PMC: 10821705. DOI: 10.1093/ecco-jcc/jjad130.


An Improved Score for the Evaluation of Mucosal Healing in Inflammatory Bowel Disease-A Pilot Study.

Neamti L, Drugan T, Drugan C, Silaghi C, Ciobanu L, Craciun A J Clin Med. 2023; 12(4).

PMID: 36836199 PMC: 9965026. DOI: 10.3390/jcm12041663.


How to assess endoscopic disease activity in ulcerative colitis in 2022.

Ruscio M, Cedola M, Mangone M, Brighi S Ann Gastroenterol. 2022; 35(5):462-470.

PMID: 36061162 PMC: 9399578. DOI: 10.20524/aog.2022.0732.

References
1.
Mak W, Buisson A, Andersen Jr M, Lei D, Pekow J, Cohen R . Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis. Dig Dis Sci. 2018; 63(5):1294-1301. DOI: 10.1007/s10620-018-4980-0. View

2.
Walmsley R, Ayres R, Pounder R, Allan R . A simple clinical colitis activity index. Gut. 1998; 43(1):29-32. PMC: 1727189. DOI: 10.1136/gut.43.1.29. View

3.
Takashima S, Kato J, Hiraoka S, Nakarai A, Takei D, Inokuchi T . Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test. Am J Gastroenterol. 2015; 110(6):873-80. DOI: 10.1038/ajg.2015.66. View

4.
Waugh N, Cummins E, Royle P, Kandala N, Shyangdan D, Arasaradnam R . Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess. 2013; 17(55):xv-xix, 1-211. PMC: 4781415. DOI: 10.3310/hta17550. View

5.
Ikeya K, Hanai H, Sugimoto K, Osawa S, Kawasaki S, Iida T . The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score. J Crohns Colitis. 2015; 10(3):286-95. PMC: 4957474. DOI: 10.1093/ecco-jcc/jjv210. View